Lakewood-Amedex Biotherapeutics Inc. - 8-K Filing

Lakewood-Amedex Biotherapeutics redeems all outstanding Series C Convertible Preferred Stock for $1,270,970 in cash. (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $LABT

Read the full article at SEC EDGAR

Part of the story Lakewood-Amedex Biotherapeutics Completes Redemption of Series C Convertible Preferred Stock (2 articles)

More Regulatory news